These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15666822)

  • 21. Effects of estrogen replacement therapy on dehydroepiandrosterone, dehydroepiandrosterone sulfate, and cortisol responses to exercise in postmenopausal women.
    Johnson LG; Kraemer RR; Haltom R; Kraemer GR; Gaines HE; Castracane VD
    Fertil Steril; 1997 Nov; 68(5):836-43. PubMed ID: 9389812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The involvement of dehydroepiandrosterone (DHEA) and its sulfate ester (DHEAS) in blocking the therapeutic effect of electroconvulsive shocks in an animal model of depression.
    Maayan R; Morad O; Dorfman P; Overstreet DH; Weizman A; Yadid G
    Eur Neuropsychopharmacol; 2005 May; 15(3):253-62. PubMed ID: 15820413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence.
    Straub RH; Konecna L; Hrach S; Rothe G; Kreutz M; Schölmerich J; Falk W; Lang B
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2012-7. PubMed ID: 9626133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term daily oral administration to healthy young men.
    Acacio BD; Stanczyk FZ; Mullin P; Saadat P; Jafarian N; Sokol RZ
    Fertil Steril; 2004 Mar; 81(3):595-604. PubMed ID: 15037408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor necrosis factor inhibits conversion of dehydroepiandrosterone sulfate (DHEAS) to DHEA in rheumatoid arthritis synovial cells: a prerequisite for local androgen deficiency.
    Weidler C; Struharova S; Schmidt M; Ugele B; Schölmerich J; Straub RH
    Arthritis Rheum; 2005 Jun; 52(6):1721-9. PubMed ID: 15934093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High doses of systemic DHEA-sulfate do not affect sleep structure and elicit moderate changes in non-REM sleep EEG in rats.
    Schiffelholz T; Holsboer F; Lancel M
    Physiol Behav; 2000 Jun 1-15; 69(4-5):399-404. PubMed ID: 10913777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of the neurosteroid dehydroepiandrosterone sulfate with the GABA(A) receptor complex reveals that it may act via the picrotoxin site.
    Sousa A; Ticku MK
    J Pharmacol Exp Ther; 1997 Aug; 282(2):827-33. PubMed ID: 9262347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women.
    Genazzani AD; Stomati M; Strucchi C; Puccetti S; Luisi S; Genazzani AR
    Fertil Steril; 2001 Aug; 76(2):241-8. PubMed ID: 11476767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) inhibit the apoptosis in human peripheral blood lymphocytes.
    Takahashi H; Nakajima A; Sekihara H
    J Steroid Biochem Mol Biol; 2004 Mar; 88(3):261-4. PubMed ID: 15120419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroactive neurosteroids: dehydroepiandrosterone (DHEA) and DHEA sulphate.
    Baulieu EE
    Acta Paediatr Suppl; 1999 Dec; 88(433):78-80. PubMed ID: 10626550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do DHEA/DHEAS play a protective role in coronary heart disease?
    Porsová-Dutoit I; Sulcová J; Stárka L
    Physiol Res; 2000; 49 Suppl 1():S43-56. PubMed ID: 10984071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3 beta-hydroxysteroid dehydrogenase.
    Endoh A; Kristiansen SB; Casson PR; Buster JE; Hornsby PJ
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3558-65. PubMed ID: 8855801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and the subsequent risk of developing colon cancer.
    Alberg AJ; Gordon GB; Hoffman SC; Comstock GW; Helzlsouer KJ
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):517-21. PubMed ID: 10815698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
    Labrie F; Bélanger A; Cusan L; Candas B
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of dehydroepiandrosterone (DHEA)/DHEA-sulfate (DHEAS) on the contraction responses of the clitoral cavernous smooth muscle from female rabbits.
    Lee SY; Myung SC; Lee MY; Kim TH; Kim SC; Kim KD; Park SH; Kim WY
    J Sex Med; 2009 Oct; 6(10):2653-60. PubMed ID: 19627466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dehydroepiandrosterone sulfate, a useful endogenous probe for evaluation of drug-drug interaction on hepatic organic anion transporting polypeptide (OATP) in cynomolgus monkeys.
    Watanabe M; Watanabe T; Yabuki M; Tamai I
    Drug Metab Pharmacokinet; 2015 Apr; 30(2):198-204. PubMed ID: 25989893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioavailability and pharmacokinetics of dehydroepiandrosterone in the cynomolgus monkey.
    Leblanc M; Labrie C; Bélanger A; Candas B; Labrie F
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4293-302. PubMed ID: 12970301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression.
    Arlt W; Justl HG; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1928-34. PubMed ID: 9626121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of dehydroepiandrosterone and its sulfate metabolite on neuronal cell viability in culture.
    Gil-ad I; Shtaif B; Eshet R; Maayan R; Rehavi M; Weizman A
    Isr Med Assoc J; 2001 Sep; 3(9):639-43. PubMed ID: 11574977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dehydroepiandrosterone in systemic lupus erythematosus: relationship between dosage, serum levels, and clinical response.
    Barry NN; McGuire JL; van Vollenhoven RF
    J Rheumatol; 1998 Dec; 25(12):2352-6. PubMed ID: 9858429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.